BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 87148)

  • 1. [Joint therapy of experimental tumors with diazan in combination with antibiotics].
    Volkova LM; D'iachkovskaia RF; Konovalova NP
    Antibiotiki; 1979 Apr; 24(4):300-3. PubMed ID: 87148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antitumor activity of doxorubicin in the treatment of hemocytoblastosis La and various ascites tumors in mice].
    Ul'ianova LA; Tarasova VE; Bazhanov VS; Iudina OI; Gol'dberg LE
    Antibiotiki; 1984 Nov; 29(11):861-6. PubMed ID: 6524889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Factor analysis of the effectiveness of combined therapy in experimental leukemia].
    Emanuél' NM; Konovalova NP; Volkova LM; Rusanov VV
    Vopr Onkol; 1979; 25(6):96-100. PubMed ID: 462879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combination chemotherapy of experimental leukemia].
    Emanuel' NM; Konovalova NP; D'iachkovskaia RF
    Vopr Onkol; 1977; 23(5):62-6. PubMed ID: 888420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative experimental study of the antileukemia activity of carminomycin and rubomycin].
    Khanykova OK; Vinogorova GF
    Antibiotiki; 1977 Sep; 22(9):846-52. PubMed ID: 911158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of 1,2-bis diazoacetyl ethane.
    Emanuel NM; Konovalova NP; Djachkovskaya RF
    Cancer Treat Rep; 1976 Nov; 60(11):1601-4. PubMed ID: 191190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.
    Quintieri L; Rosato A; Napoli E; Sola F; Geroni C; Floreani M; Zanovello P
    Cancer Res; 2000 Jun; 60(12):3232-8. PubMed ID: 10866316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antineoplastic activity of antibiotic 1719 from the group of diazo compounds].
    Shorin VA; Averbukh LA; Bazhanov VS; Lepeshkina GN; Grinshteĭn AM
    Antibiotiki; 1972 Aug; 17(8):675-80. PubMed ID: 4678532
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antitumor activity and toxicity of combined doxorubicin and disodium salt of methylene-1,1-diphosphonic acid].
    Stukov AN; Mironiuk TN; Kon'kov SA; Krylova IM; Reztsova VV; Filov VA; Ivin BA
    Vopr Onkol; 1998; 44(1):100-2. PubMed ID: 9578741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of pyrazofurin in combination with 5-azacytidine against murine P388 and L1210 leukemias and colon carcinoma 26.
    Chiuten DF; Muggia FM; Johnson RK
    Cancer Treat Rep; 1979; 63(11-12):1857-62. PubMed ID: 93512
    [No Abstract]   [Full Text] [Related]  

  • 11. Antitumor effects of azaserine and DON.
    Burchenal JH
    Cancer Treat Rep; 1979 Jun; 63(6):1031-2. PubMed ID: 466642
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antitumor activity of carminomycin antibiotic used orally].
    Shorin VA; Bazhanov VS; Averbukh LA
    Antibiotiki; 1976 Nov; 21(11):1005-7. PubMed ID: 1037187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antitumor activity and preclinical pharmacologic evaluation of pingyangmycin (author's transl)].
    Lin FT; Li DD; Yang XP; Li Q; Xue YC; Zhen YS
    Zhonghua Zhong Liu Za Zhi; 1979; 1(3):161-6. PubMed ID: 95444
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effectiveness of free and liposomal forms of platinum and anthracycline antibiotics for hepatic metastasis of GA-1 and P-388 tumors in mice].
    Kaledin VI; Il'nitskaia SI
    Vopr Onkol; 1996; 42(3):64-6. PubMed ID: 8801744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic performance of carminomycin-cyclophosphamide against L1210 leukemia.
    Avery TL; Cruze PG
    Cancer Res; 1978 Sep; 38(9):2892-5. PubMed ID: 679196
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effectiveness of nitrosomethylurea derivatives in the combined chemotherapy of experimental tumors].
    Krutova TV; Ostrovskaia LA
    Eksp Onkol; 1986; 8(5):47-50. PubMed ID: 3780511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The potential for enhancing the therapeutic efficacy of antitumor preparations].
    Konovalova NP; Volkova LM; Klochko AV
    Izv Akad Nauk SSSR Biol; 1989; (3):466-8. PubMed ID: 2760333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combined effect of PT-050 (recombinant human TNF) and antitumor drugs on syngeneic murine tumors].
    Nakata K; Yoshida H; Kashimoto S; Sohmura Y; Nakamura S; Taguchi T
    Gan To Kagaku Ryoho; 1986 Oct; 13(11):3186-93. PubMed ID: 3096217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
    Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
    Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental and clinical data on the antitumor action of hydrazine sulfate].
    Seĭts IF; Gershanovich ML; Filov VA; Danova LA; Kondrat'ev VB
    Vopr Onkol; 1975; 21(1):45-52. PubMed ID: 1090085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.